KORU Medical Systems Q3 2026 earnings

KRMD · 2026-11-10 16:43 AMC ET · 8-K on SEC

Revenue grew 12.4% year-over-year to $31.4 million, but adjusted EBITDA margin contracted by 2.2 percentage points to 13.9%.

Headline numbers

MetricActualYoYQoQ8-K location
Revenue$31.4 million+12.4%+4.9%Ex. 99.1, Financial Highlights
EPS (GAAP)$0.03+0.01+0.01Ex. 99.1, Financial Highlights
EPS (adjusted)$0.05+0.01+0.01Ex. 99.1, Financial Highlights
Net income$2.1 million+0.7 million+0.7 millionEx. 99.1, Financial Highlights
Adj. EBITDA$4.4 million+0.5 million+0.2 millionEx. 99.1, Financial Highlights
Adj. EBITDA margin13.9%-2.2 pp-0.5 ppEx. 99.1, Financial Highlights

Revenue breakdown

SegmentActualYoYShare of revenueNote
North America$17.4 million+13.7%55%—
International$14.0 million+10.9%45%—

Margins and costs

  • Gross margin 53.8% (prior 54.5%, change -0.7 pp)
  • Operating expenses $14.4 million (+11.2% YoY)
  • One-offs in the quarter Tax benefit of $0.3 million related to foreign tax credit carryforwards; Restructuring charges of $0.2 million
  • Effective tax rate 20.0% (prior-year 20.0%, year-to-date 20.0%)
  • Non-GAAP bridge Adds back stock-based compensation ($0.8 million) and restructuring charges ($0.2 million).

KPIs

MetricActualPrior quarterPrior yearChange
Free cash flow$2.8 million$2.6 million$2.5 million+0.2 million
Days sales outstanding48 days49 days50 days-1 day
Cash and cash equivalents$25.4 million$22.8 million$21.9 million+2.6 million

Guidance

MetricGuidePrior guideChange
Revenue$30.0 million - $32.0 million$30.0 million - $32.0 million—
Adjusted EBITDA$3.5 million - $4.5 million$3.5 million - $4.5 million—

What drove it

  • Revenue story Revenue grew 12.4% year-over-year, driven by 13.7% growth in North America and 10.9% growth in International.
  • EPS story Adjusted EPS increased by $0.01 year-over-year, driven by higher revenue and a lower tax rate.
  • One-off check Tax benefit of $0.3 million related to foreign tax credit carryforwards and restructuring charges of $0.2 million.

The good

  • Revenue growth of 12.4% year-over-year
  • Adjusted EBITDA of $4.4 million
  • Free cash flow of $2.8 million

The bad

  • Adjusted EBITDA margin contracted by 2.2 percentage points year-over-year
  • Operating expenses increased 11.2% year-over-year

The ugly

  • none

Open questions

  • What specific factors drove the 11.2% increase in operating expenses?
  • Why did the adjusted EBITDA margin contract despite revenue growth?
Full release

KORU Medical Systems (KRMD) earnings release, November 10, 2026

KORU Medical Systems, Inc. (KRMD) · Form 8-K, Item 2.02 · Filed · SEC filing

Attachments

Seq Document Description

───────────────────────────────────────────────────────────────────────────────

2 ex_99-1.htm PRESS RELEASE, DATED NOVEMBER 10, 2026

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · KORU Medical Systems earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.